Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in neoadjuvant treatment of locally advanced rectal cancer
NCT02473094Phase 2Terminated
- Sponsor
- Universidade Estadual de Campinas
- Start
- Jul 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rectal cancer comparing Metformin Arm with Placebo Arm (2 arms). Primary endpoint: Pathological Complete Response. Started Jul 2015; status: terminated.
02
Drugs
metformin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02473094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473094.